Evidence map›Paper›PMID 41552308›Full record

ArticleAmerican journal of translational research2025

Analysis of factors influencing the efficacy of YAG laser vitreolysis for symptomatic vitreous opacities and prediction of postoperative complication risks: a retrospective cohort study.

Li Yan, Fan Zhang, Xiuping Zhang

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li YanDepartment of Ophthalmology, Shandong Provincial Third Hospital, Shandong University Ji'nan 250031, Shandong, China.
Fan ZhangDepartment of Ophthalmology, Shandong Provincial Third Hospital, Shandong University Ji'nan 250031, Shandong, China.
Xiuping ZhangDepartment of Ophthalmology, Shandong Provincial Third Hospital, Shandong University Ji'nan 250031, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify factors influencing the efficacy of Yttrium Aluminum Garnet (YAG) laser vitreolysis for symptomatic vitreous opacities and to establish a risk prediction model for postoperative complications.

methodsThis retrospective study included 130 patients with symptomatic vitreous opacities who underwent YAG laser vitreolysis from January 2022 to December 2024. The relationships between patient demographics, clinical characteristics, surgical parameters, and treatment efficacy were analyzed. Multivariate logistic regression was applied to identify independent predictive factors for treatment efficacy. A risk prediction model for complications was constructed and evaluated using receiver operating characteristic (ROC) curve analysis.

resultsAt 3 months postoperatively, 78 (60.0%), 32 (24.6%), and 20 (15.4%) patients experienced marked, partial, and no improvement, respectively. Multivariate analysis identified age (OR=1.052, 95% CI: 1.012-1.093), disease duration (OR=1.105, 95% CI: 1.032-1.183), degree of vitreous opacity (OR=2.356, 95% CI: 1.325-4.187), and laser energy (OR=1.872, 95% CI: 1.235-2.841) as independent factors influencing efficacy (all P<0.05). Postoperative complications occurred in 70 (53.8%) patients. The prediction model demonstrated good performance, with an area under the curve (AUC) of 0.792, sensitivity of 0.714, and specificity of 0.667.

conclusionsThe efficacy of YAG laser vitreolysis is influenced by multiple factors. The established complication risk prediction model shows good predictive ability and may aid clinical decision-making.

Indexed as

efficacyinfluencing factorspostoperative complicationsrisk predictionsymptomatic vitreous opacitiesYttrium Aluminum Garnet (YAG) laser vitreolysis

Identifiers

PMID41552308
PMCPMC12808023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.